Stocks and Investing Stocks and Investing
Tue, March 9, 2021
[ 12:00 AM ] - WOPRAI
Kelvin Lau Upgraded (XPEV) to Strong Buy and Held Target at $34 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Nitin Kumar Upgraded (AR) to Hold and Held Target at $12 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (AREC) at Strong Buy with Increased Target to $4.5 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Richard Ciciarelli Downgraded (ATO) to Hold on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Craig Irwin Maintained (ASYS) at Strong Buy with Increased Target to $15 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Steve Barger Maintained (AIT) at Buy with Increased Target to $98 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Laws Maintained (AJX) at Buy with Increased Target to $14 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Caitlin Burrows Downgraded (BRX) to Hold and Increased Target to $22 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
James Terwilliger Upgraded (ZYXI) to Buy on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Bill Herbert Downgraded (WHD) to Hold and Held Target at $32 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Steven Zaccone Initiated (WSM) at Hold and Held Target at $64 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Kimberly Greenberger Maintained (AEO) at Hold with Increased Target to $25 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Pierre Ferragu Upgraded (TSLA) to Strong Buy and Held Target at $300 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Steven Zaccone Initiated (TSCO) at Hold and Held Target at $158 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Tom Hughes Downgraded (SM) to Hold and Held Target at $21 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Pavel Molchanov Initiated (SOL) at Buy and Held Target at $15 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Patrick Ho Upgraded (CAMT) to Strong Buy and Increased Target to $30 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Billy Kovanis Maintained (CAR) at Buy with Increased Target to $67 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Brian Mullan Downgraded (BLMN) to Hold and Held Target at $28 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Gabe Daoud Initiated (BLNK) at Buy and Held Target at $38 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Gabe Daoud Initiated (BEEM) at Hold and Held Target at $33 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
David Coleman Upgraded (BHP) to Strong Buy and Held Target at $87 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Steven Zaccone Initiated (BBY) at Strong Sell and Held Target at $86 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Steve Barger Maintained (AME) at Buy with Increased Target to $131 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Steven Zaccone Initiated (AAP) at Strong Buy and Held Target at $193 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Fein Maintained (ACAD) at Strong Buy with Decreased Target to $43 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Stringer Maintained (ACAD) at Strong Buy with Decreased Target to $44 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Paul Matteis Downgraded (ACAD) to Hold and Decreased Target to $27 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Danielle Brill Downgraded (ACAD) to Buy and Decreased Target to $35 on, Mar 9th, 2021
[ 12:00 AM ] - WOPRAI
Jeffrey Hung Maintained (ACAD) at Buy with Decreased Target to $50 on, Mar 9th, 2021

Jeffrey Hung Maintained (ACAD) at Buy with Decreased Target to $50 on, Mar 9th, 2021


Published on 2024-10-27 15:53:16 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Buy with Decreased Target from $65 to $50 on, Mar 9th, 2021.

Jeffrey has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Jeffrey's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jeffrey

  • Vamil Divan of "Mizuho" Initiated at Strong Buy and Held Target at $69 on, Wednesday, December 16th, 2020
Contributing Sources